Clinical Trials in San Francisco

Showing 9201-9220 of 12,991 trials

Abiraterone Post Ketoconazole for Prostate Cancer

NCT01199146

This is a phase II, open label, single center study to evaluate the efficacy of abiraterone acetate (CB7630) administered to patients with castrate resistant prostate cancer who have experienced disease progression on ketoconazole. It is hypothesized that abiraterone will be active in patients who have experienced disease progression on ketoconazole

Prostate Cancer

University of California, San Francisco42 participantsStarted Sep 2010

San Francisco, California, United States • Chicago, Illinois, United States

COMPLETEDPhase 2< 1 mile

Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma

NCT01693068

This is a Phase 2, multicenter, randomized, controlled, open-label trial of pimasertib versus dacarbazine aimed to confirm the activity of pimasertib in previously untreated subjects with N-Ras mutated locally advanced or metastatic malignant cutaneous melanoma by comparing the progression-free survival (PFS) of subjects treated with either pimasertib or dacarbazine and by getting a better understanding of the efficacy, safety, pharmacogenomics (PGx) and their relationship with pimasertib exposure.

N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

EMD Serono194 participantsStarted Dec 2012

Birmingham, Alabama, United States • Tucson, Arizona, United States • San Francisco, California, United States +98 more locations

Abiraterone Post Ketoconazole for Prostate Cancer

Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma

Find Trials by Condition in San Francisco

Simvastatin Therapy for Moderate and Severe COPD

Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme

Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)

DTS Blood Glucose Monitor System Surveillance Program SubStudy 1

Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus

Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDS

Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in Obesity

Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma

Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma

KAVIAR Study - Kyphoplasty And Vertebroplasty In the Augmentation and Restoration of Vertebral Body Compression Fractures

Condition of Approval Study

Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome

A Safety Study of SGN-CD33A in AML Patients

A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.

Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer